Veradigm | MDRX - Beneficio Bruto En Ventas

Precio De Mercado
4.55
Cambio Diario
-0.03 -0.66%
Mensual
1.11%
Anual
4.36%
Q1 Expectativa
4.44




Beneficio Bruto En Ventas Cambio Fecha
Alcidion AUD 21.02M 5.65M 2025-12
Ambu A/S DKK 947M 68M 2025-12
Amplifon EUR 103.17M 44.14M 2025-09
Cardinal Health USD 2.4B 78M 2025-12
Centene USD 2.14B 796M 2025-12
Charles River Laboratories USD 271.96M 39.43M 2025-12
Cigna USD 56.45B 50.29B 2025-09
Coloplast 4.74B 27M 2025-12
Computer Programs Systems USD 38.85M 1.64M 2023-09
Convatec Group USD 660.5M 348.95M 2024-12
CVS Health USD 13.57B 239M 2025-12
Diasorin EUR 181.08M 19.92M 2025-09
Elevance Health USD 11.68B 889M 2025-12
General Electric Aerospace USD 3.8B 118M 2025-12
Gulf Medical Proj AED 46.22M 8.48M 2025-03
Humana USD 4.82B 754M 2025-06
IQVIA Holdings USD 1.12B 32M 2025-12
Laboratory Of America USD 993.2M 31.9M 2025-12
Maximus USD 318.67M 14.88M 2025-12
McKesson USD 3.68B 143M 2025-12
Med Life RON 628.26M 7.99M 2025-09
Molina Healthcare USD 1.2B 193M 2025-12
Omnicell USD 130.32M 4.18M 2025-12
Oriola-kd EUR 40.2M 2.1M 2025-09
Owens Minor USD 272.05M 20.92M 2025-12
Quest Diagnostics USD 873M 37M 2025-12
Rede D'or Sao Luiz BRL 3.18B 176.73M 2025-12
Siemens Healthineers EUR 2.08B 299M 2025-12
Sonova Holding CHF 1.28B 205.2M 2025-12
Supermax Corporation Bhd MYR -143.15M 161.11M 2025-09
UnitedHealth USD 20.64B 77.96B 2025-09
Veeva Systems USD 622.47M 7.11M 2025-12
Veradigm USD 83.44M 3.95M 2022-09
Xerox USD 441M 15M 2025-06